RBC Bearings (RBC) Q4 2026 earnings review
A&D Supercycle Powers Record Year, Backlog Reaches $2.3B
RBC Bearings delivered an exceptional close to FY26, with Q4 sales accelerating to 18.3% YoY growth ($518.0M) and Adjusted EPS surging 27.9% to $3.62. The growth engine remains Aerospace & Defense, expanding 41.2% YoY, aided by the VACCO acquisition and an unprecedented submarine and commercial aerospace supercycle. The company's backlog has exploded from $0.9B a year ago to an astonishing $2.3B. Industrial markets are showing signs of stabilization, up 5.5% YoY. With Adjusted Gross Margins hitting 45.3% despite VACCO's initial dilution, management is executing its integration and pricing playbook flawlessly. Guidance for 27Q1 anticipates continued double-digit headline growth, capping off a structurally transformative year.
🐂 Bull Case
The backlog sits at $2.3 billion, representing more than a full year of revenue. Multi-year defense contracts and OEM production ramps provide RBC with a level of demand visibility rarely seen in industrial manufacturing.
Despite acquiring lower-margin VACCO in Q2, consolidated Adjusted Gross Margin expanded to 45.3% in Q4 (up 110 bps YoY). Operational synergies and favorable pricing are materializing faster than expected.
🐻 Bear Case
Management has repeatedly noted that demand significantly exceeds capacity for plants representing 70% of A&D revenue. Translating a $2.3B backlog into actual sales will require flawless capital and labor execution.
While Q4 headline revenue grew 18.3%, adjusting for the $30M VACCO contribution reveals organic growth closer to 11.5%. The underlying Industrial segment remains a mid-single-digit grower.
⚖️ Verdict: 🟢🟢
Bullish. RBC Bearings is riding a generational wave in Aerospace & Defense. The sheer magnitude of their backlog ($2.3B), coupled with proven margin expansion capabilities, heavily outweighs near-term capacity bottleneck risks.
Key Themes
Aerospace & Defense Supercycle Accelerating
The A&D segment is experiencing explosive growth, accelerating from roughly 10% early in the year to 41.2% in Q4. This is driven by massive, multi-year initiatives in US/NATO defense spending, specifically the Virginia and Columbia-class submarine build-outs, alongside a broader commercial aerospace ramp-up. A&D now makes up 42.8% of total revenue, rapidly closing the gap with the Industrial segment.
Historic Backlog Expansion
RBC's backlog has become its defining metric. From $0.9B at the end of FY25, it ballooned to $2.3B by the end of 26Q4. While the VACCO acquisition added roughly $0.5B, the organic growth in multi-year defense and commercial aerospace orders has fundamentally transformed the company's long-term revenue visibility.
Flawless VACCO Integration and Synergies
Acquired in July 2025, VACCO contributed $30.0M to Q4 sales. Initially viewed as a margin dilutive asset (VACCO historic margins ~25-30% vs RBC's ~44%), management's playbook of operational improvements and pricing adjustments has already allowed corporate adjusted gross margins to hit 45.3%. The margin headwind was absorbed with remarkable speed.
Quiet Valves Dominating Submarine Supply Chain
A specific technology driver for the A&D segment is the supply of proprietary, sole-source quiet running valves and actuators. Combining the legacy Sargent marine business with VACCO has positioned RBC as a dominant supplier for the #1 US defense priority: the construction of 66 Virginia-class and 12 Columbia-class submarines.
Capacity Limits Act as a Growth Ceiling
The primary risk to RBC is an operational one. Management has previously noted that for 70% of the A&D revenue base, demand is significantly over capacity. While Q4 revenue of $518M beat estimates, the company's ability to hire, add shifts, and complete CapEx efficiently is the sole bottleneck preventing even faster backlog conversion.
Divergence Between Organic and Headline Growth
While total Q4 revenue grew 18.3%, organic growth remains notably lower. Q1 2027 guidance estimates total growth at 14.7% - 17.0%, but explicitly states that excluding VACCO, net sales will grow 8.3% - 10.6%. A 600+ bps gap suggests that without M&A, the company's growth profile is closer to high-single-digits.
Industrial Segment Heavily Reliant on Aftermarket
The Industrial segment showed stable 5.5% growth, a modest acceleration from Q3's 3.1%. However, historical commentary indicates this is almost entirely supported by distribution and aftermarket resiliency. The industrial OEM market (heavy machinery, European machine tools) remains sluggish, limiting the segment's upside.
Other KPIs
Accelerating significantly from $293.6M in 25FY. This massive cash generation fueled the $276.7M acquisition of VACCO while still allowing for aggressive debt repayments. Total debt (current + long-term) dropped to $875.5M by year-end, proving the company's rapid deleveraging capabilities post-M&A.
Stable and impressive. Up slightly from 31.8% in 25FY. The fact that EBITDA margins expanded during a year where a margin-dilutive acquisition was integrated highlights excellent pricing power and overhead absorption via higher production volumes.
Guidance
Decelerating slightly on a sequential basis from Q4's record $518M, but represents strong 14.7% to 17.0% YoY growth. Adjusting out the expected $28M from VACCO, the core business is guided to grow at a healthy 8.3% to 10.6% pace.
Stable compared to 26Q4's 45.3% and representing a solid 45 bps YoY expansion at the midpoint versus 26Q1 (44.8%). Indicates that operational synergies from the Dodge and VACCO integrations continue to compound.
Stable. In line with the 16.8% posted in 26Q4. The company continues to exercise tight cost control, allowing gross margin improvements to flow directly to the bottom line.
Key Questions
Capacity CapEx Requirements
With the backlog surging from $2.1B to $2.3B in just one quarter, are current CapEx budgets (historically ~3.5% of sales) sufficient to add the necessary physical capacity, or will we see a step-up in investment in FY27?
VACCO Margin Integration Timeline
Adjusted gross margins hit 45.3% this quarter. Is VACCO already tracking at corporate average margins, or is the core business outperforming enough to mask ongoing dilution? What is the specific timeline for VACCO to reach 40%+ margins?
Industrial OEM Health
Industrial revenue accelerated to 5.5% growth. Can you disaggregate how much of this was driven by aftermarket/distribution versus a true bottoming out and recovery in heavy industrial OEM orders?